Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$433K Hold
1,835
0.18% 76
2020
Q1
$372K Hold
1,835
0.18% 81
2019
Q4
$442K Buy
1,835
+16
+0.9% +$3.53K 0.18% 83
2019
Q3
$352K Hold
1,819
0.15% 95
2019
Q2
$335K Sell
1,819
-186
-9% -$33.3K 0.15% 95
2019
Q1
$381K Buy
2,005
+21
+1% +$4.01K 0.18% 86
2018
Q4
$386K Sell
1,984
-17
-0.8% -$3.32K 0.2% 82
2018
Q3
$415K Buy
2,001
+72
+4% +$14.2K 0.19% 84
2018
Q2
$356K Buy
1,929
+10
+0.5% +$1.77K 0.17% 90
2018
Q1
$327K Sell
1,919
-43
-2% -$7.89K 0.16% 94
2017
Q4
$341K Buy
+1,962
New +$347K 0.16% 96

Other funds holding AMGN

TrueWealth LLC's AMGN Position: Q2 2020 in Review

TrueWealth LLC held its Amgen (AMGN) position steady in Q2 2020 at 1,835 shares worth $433K. The position accounts for 0.18% of the portfolio, ranked #76.

TrueWealth LLC first reported a position in AMGN in Q4 2017 and has held it in 11 quarters since. The position peaked at $442K in Q4 2019. 2,091 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • TrueWealth LLC held 1,835 shares of Amgen worth $433K as of Q2 2020.
  • TrueWealth LLC left its Amgen share count unchanged in Q2 2020.
  • Amgen made up 0.18% of TrueWealth LLC's portfolio in Q2 2020, its #76 holding.
  • TrueWealth LLC first reported a position in Amgen in Q4 2017 and has held it in 11 quarters since.
  • TrueWealth LLC's Amgen position peaked at $442K in Q4 2019.
  • 2,091 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.